OP
GILD icon

ORG Partners’s Gilead Sciences GILD Stock Holding History

ORG Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.19M Buy
66,686
+20
+0% +$2.43K 1.44% 10
2025
Q3 		$7.4M Buy
66,666
+299
+0.5% +$34K 1.35% 10
2025
Q2 		$7.42M Buy
66,367
+344
+0.5% +$36.6K 1.58% 12
2025
Q1 		$7.35M Sell
66,023
-294
-0.4% -$30.3K 1.81% 10
2024
Q4 		$6.13M Buy
66,317
+225
+0.3% +$20.3K 0.83% 32
2024
Q3 		$5.54M Sell
66,092
-1,127
-2% -$86K 0.89% 24
2024
Q2 		$4.61M Buy
67,219
+3,792
+6% +$253K 0.57% 36
2024
Q1 		$4.62M Sell
63,427
-4,749
-7% -$365K 8.79% 2
2023
Q4 		$5.52M Buy
68,176
+863
+1% +$67.2K 0.92% 28
2023
Q3 		$5.04M Buy
67,313
+380
+0.6% +$29.2K 1.49% 10
2023
Q2 		$5.13M Buy
66,933
+19
+0% +$1.51K 0.83% 24
2023
Q1 		$5.57M Buy
+66,914
New +$5.54M 1.36% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ORG Partners's GILD Position: Q4 2025 in Review

ORG Partners increased its Gilead Sciences (GILD) stake by 0.03% in Q4 2025, buying an estimated $2.43K and bringing the position to 66,686 shares worth $8.19M. The position accounts for 1.44% of the portfolio, ranked #10.

ORG Partners first reported a position in GILD in Q1 2023 and has held it in 12 quarters since. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • ORG Partners held 66,686 shares of Gilead Sciences worth $8.19M as of Q4 2025.
  • ORG Partners bought 20 Gilead Sciences shares in Q4 2025, an estimated $2.43K.
  • Gilead Sciences made up 1.44% of ORG Partners's portfolio in Q4 2025, its #10 holding.
  • ORG Partners first reported a position in Gilead Sciences in Q1 2023 and has held it in 12 quarters since.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.